First trimester screening for aneuploidy: Serum biochemical markers

This publication has 56 references indexed in Scilit:

• Antenatal Screening for Down's Syndrome
  Journal of Medical Screening, 1997
• Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome
  Prenatal Diagnosis, 1997
• Maternal serum screening for Down syndrome in the United States: A 1995 survey
  American Journal of Obstetrics and Gynecology, 1997
• PRENATAL SCREENING FOR DOWN'S SYNDROME USING INHIBIN-A AS A SERUM MARKER
  Prenatal Diagnosis, 1996
• Serum PAPP‐A measurements in first‐trimester screening for Down syndrome
  Prenatal Diagnosis, 1993
• Supported in part by grant No. HD04612 to the Mental Retardation Research Center. Presented at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 1118, 1992.
  American Journal of Obstetrics and Gynecology, 1993
• Low maternal serum levels of pregnancy associated plasma protein A (PAPP‐A) in the first trimester in association with abnormal fetal karyotype
  BJOG: An International Journal of Obstetrics and Gynaecology, 1993
• First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome.
  BMJ, 1992
• FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME
  The Lancet, 1988
• FETAL CHROMOSOMAL ANEUPLOIDIES AND MATERNAL SERUM ALPHA-FETOPROTEIN LEVELS IN FIRST TRIMESTER
  The Lancet, 1986